Triangle biotech startup emerges with a bang – $49M and 4 drug candidates
Five years after launching with a team headlined by local life sciences “rainmaker” Steve Butts and $49 million in capital, Arrivo BioVentures is emerging from stealth mode.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
